Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
What is the purpose of this trial?
The purpose of this study is to characterize the safety of oxycodone hydrochloride (HCl) controlled-release (CR) tablets in opioid tolerant pediatric patients aged 6 to 16 years, inclusive, with moderate to severe malignant and/or nonmalignant pain requiring opioid therapy.
- 6 Years - 16 Years
- Purdue Pharma LP
- November 2010
- Last Updated:
- March 20, 2013
- Study HIC#:
Clinicaltrials.gov ID: NCT01192295